Baidu
map

CCI 2016|“创心”心血管诊疗技术和器械创新大赛总决赛前期培训会上海举行

2016-05-10 医声网 医声网

2016年5月8日,“创心”心血管诊疗技术和器械创新大赛总决赛前期培训会在上海复旦大学附属中山医院介入会议室举行。 “创心”背景“创心”心血管诊疗技术和器械创新大赛自2015年9月11日开始正式接受选手报名和投稿,于2015年12月31日截止。经过了大会组委会严格的审阅和评选过程,于2016年3月公布了最终进入现场决赛的10位选手名单。为了提前让选手熟悉总决赛流程,同时也为了指导正处于火

2016年5月8日,“创心”心血管诊疗技术和器械创新大赛总决赛前期培训会在上海复旦大学附属中山医院介入会议室举行。

 
“创心”背景

“创心”心血管诊疗技术和器械创新大赛自2015年9月11日开始正式接受选手报名和投稿,于2015年12月31日截止。经过了大会组委会严格的审阅和评选过程,于2016年3月公布了最终进入现场决赛的10位选手名单。

为了提前让选手熟悉总决赛流程,同时也为了指导正处于火热备战阶段的10位选手更好地在总决赛现场有出色表现,本次大赛主办方中国心血管医生创新俱乐部、中国心血管健康联盟,联合大赛协办方心峰汇、火石创造、北京健康促进会共同举办了这次前期培训会,由鸿时宏涛医疗健康产业基金创始管理合伙人王莉女士和钟伟博士担任培训导师,对总决赛选手进行了1对1培训。

CCI秘书长沈雳教授主持培训会


本次培训会由中国心血管医生创新俱乐部(CCI)秘书长、教育部心血管介入治疗技术与器械工程研究中心副主任沈雳教授全程主持。沈雳教授首先对经过严格评审最终进入决赛的各位选手表示祝贺,并对各位选手在繁忙的工作之余能够参加此次培训表示感谢。在回顾大赛前期筹备及选手参赛情况时,沈雳教授表示:各位选手在临床工作之余,能够积极参与心血管技术和器械的创新活动,并最终参加这次大赛,非常难得。

之后,沈教授介绍了参加此次活动的培训师和选手,并对总决赛的初步流程、时间安排、评委构成、评选规则、项目展示、评分说明、比赛奖项等进行了详细介绍。沈雳教授表示:希望通过这次培训会的举行,能够使培训师对各位选手项目进行1对1现场点评,为最后各位选手在现场的精彩表现和大赛的顺利完成打下良好的基础。

选手欧阳晨曦分享“创新”到“创业”之路的经验 


来自国家心血管病中心阜外医院的欧阳晨曦教授作为一名非常特殊的选手,与在座各位选手分享了自己的创新历程。欧阳晨曦教授作为一名临床医生,发明了小口径人造血管,经过了研发的艰苦阶段,已经结出硕果。欧阳教授指出:真正走到创新这条路上来,才知道这条路行之不易。将临床“创新”成果转化成“创业”产品之路,更是非常艰难。本次大赛为临床医生提供了一个创新的入口,给予了临床医生一种创业的可能性,非常有意义。

之后,欧阳教授结合自己参加的多次创新培训活动经验,与各位选手分享了在现场展示产品时的种种技巧,如内容框架要丰满;言语要简练、深入浅出;逻辑思维要清晰;要对行业现状和市场潜力进行描绘、重视知识产权和专利等,给各位选手带来了总决赛现场路演的“操作指南”以及创新之路前行的经验。

鸿时宏涛医疗健康产业基金创始管理合伙人王莉女士期待国内更多创新项目落地

  

鸿时宏涛医疗健康产业基金创始管理合伙人王莉女士在整个心血管领域做了非常多的深入的研究,并与以色列、美国等创新团队有过合作和交流,王莉女士表示:在创新的过程中,不管是在以色列,还是美国硅谷,创新产业化的链条非常清晰:临床医生将在临床工作中所遇到的问题从临床需求出发,转化为临床想法;工程师和医生配合,将临床想法转化为具体产品,再由投资人和企业推动产品落地。因此,临床医生在临床领域结合临床需求的创新力量,具有巨大的价值。在国外,投资人看到了临床医生在创新领域的价值。中国有最大的样本量,最大的医生群体,最复杂的病历的多样性,相信在这片热土上,产生影响世界的医疗技术和器械创新,是非常有可能的。

本次培训会作为总决赛的预热活动,率先为总决赛的成功举办拉开了序幕,相信5月27日的总决赛会更加精彩,让我们一同期待!

入围总决赛十强选手

(按姓氏拼音排序)
姜海滨   李启洋   陆树洋   欧阳晨曦   潘文志
孙韬   夏妍   熊光磊(美国)   张健   张凌云

总决赛流程初步说明




报名通道及更多总决赛信息  :http://event.3188.la/306917999#rd

大赛的冠亚季军将获邀参加以色列“创心”探索之旅,此外还设立了最具人气、最具潜力、最佳投资价值等单项奖,所有获奖作品的参赛个人或团队可获得CCI青年会员资格

注:医生免费,进入医生通道注册后即可获得参会码

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2045702, encodeId=3a0d2045e02fe, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Jul 18 07:22:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110517, encodeId=8bdd11051edf, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110518, encodeId=cc0311051889, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85648, encodeId=6f9885648e1, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 13:45:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285253, encodeId=e9dc128525358, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu May 12 08:22:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2045702, encodeId=3a0d2045e02fe, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Jul 18 07:22:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110517, encodeId=8bdd11051edf, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110518, encodeId=cc0311051889, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85648, encodeId=6f9885648e1, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 13:45:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285253, encodeId=e9dc128525358, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu May 12 08:22:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
    2016-09-03 doctorJiangchao

    继续学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2045702, encodeId=3a0d2045e02fe, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Jul 18 07:22:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110517, encodeId=8bdd11051edf, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110518, encodeId=cc0311051889, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85648, encodeId=6f9885648e1, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 13:45:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285253, encodeId=e9dc128525358, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu May 12 08:22:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
    2016-09-03 doctorJiangchao

    继续关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2045702, encodeId=3a0d2045e02fe, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Jul 18 07:22:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110517, encodeId=8bdd11051edf, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110518, encodeId=cc0311051889, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85648, encodeId=6f9885648e1, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 13:45:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285253, encodeId=e9dc128525358, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu May 12 08:22:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
    2016-05-13 QQ6709219e

    了解一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2045702, encodeId=3a0d2045e02fe, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Jul 18 07:22:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110517, encodeId=8bdd11051edf, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=110518, encodeId=cc0311051889, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Sep 03 21:11:00 CST 2016, time=2016-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85648, encodeId=6f9885648e1, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 13:45:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285253, encodeId=e9dc128525358, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu May 12 08:22:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map